Back to top

Telix Pharmaceuticals (TLPPF) Receives a Buy from Morgan Stanley

In a report released today, David Bailey from Morgan Stanley maintained a Buy rating on Telix Pharmaceuticals, with a price target of A$25.60. The ...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Telix Pharmaceuticals Limited (TLX)